Xbrane Biopharma

Major Shareholding Notification • Dec 11, 2023

Issuer Xbrane Biopharma AB

Holder

Avanza Bank Holding AB för Försäkringsaktiebolaget Avanza Pension

Instrument
Instrument	Aktier
Before the transaction
Shares	Data not given*
Voting rights	Data not given*
Transaction
Reason for major shareholding notification Share loan
Date	08/12/2023
Limit for number of shares	5 %
Limit for number of votes	5 %
After the transaction
Quantity
Shares	1,480,787
Directly held voting rights	0
Indirectly held voting rights	1,480,787
Percentage
Directly held shares	4.96736 %
Directly held voting rights	0 %
Indirectly held voting rights	4.96736 %

Resulting distribution of total holdings

	Percentage of voting rights:	Number of underlying shares:
Shares	4.96736 %	1,480,787
Instruments - FITA Ch. 4, section 2, first paragraph, line 2
Instruments - FITA Ch. 4, section 2, first paragraph, line 3
- Physically settled
- Cash settled	0.48413 %	144,321
Total	5.45149 %	1,625,108

Group total holdings

Voting rights 1,625,108 Percentage of voting rights 5.45149

Notes (other relevant informations according to law)

Aktierna, samt övriga instrument enligt LHF 4 kap, 2§ första stycket 1 och finansiella instrument enligt LHF 4 kap. 2§ första stycket 3 innehas av Försäkringsaktiebolaget Avanza Pension som är ett helägt dotterbolag till Avanza Bank Holding AB (publ). Angivet gränsvärde har underskridits på grund av utlåning av aktier.

Published

11/12/2023 14:09

Contact

Name Marie Andersson

Email marie.andersson@avanza.se

*Source of information has chosen not to submit the data

rapportering@fi.se Tfn 08-408 980 37 Fax 08-24 39 25